Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study

In 2021, COVID-19 during pregnancy was reported to be associated with an increased risk of maternal and neonatal outcomes. The SARS-CoV-2 virus has undergone genetic mutations since then and the subsequent impact of the omicron variant on maternal and neonatal health wasunknown. This study aimed to...

Full description

Bibliographic Details
Main Authors: Villar, J, Conti, CPS, Gunier, RB, Ariff, S, Craik, R, Cavoretto, PI, Rauch, S, Gandino, S, Nieto, R, Winsey, FA, Menis, C, Rodriguez, GB, Savasi, V, Tug, N, Deantoni, S, Fabre, M, de Tejada, BM, Rodriguez-Sibaja, MJ, Livio, S, Napolitano, R, Maiz, N, Sobrero, H, Peterson, A, Deruelle, P, Giudice, C, Teji, JS, Casale, RA, Salomon, LJ, Prefumo, F, Ismail, LC, Gravett, MG, Vale, M, Hernández, V, Sentilhes, L, Easter, SR, Capelli, C, Marler, E, Cáceres, DM, Crespo, GA, Ernawati, E, Lipschuetz, M, Takahashi, K, Vecchiarelli, C, Hubka, T, Ikenoue, S, Tavchioska, G, Bako, B, Ayede, AI, Eskenazi, B, Thornton, JG, Bhutta, ZA, Kennedy, S, Papageorghiou, A
Other Authors: INTERCOVID-2022 International Consortium
Format: Journal article
Language:English
Published: Lippincott, Williams & Wilkins 2023